Skip to main content Skip to main navigation menu Skip to site footer

Carotid intima-media thickness in the first descendant of coronary artery disease patients with Apolipoprotein-E4 genotype

  • Ahmad Rafi Satrio Prayogo ,
  • Elvira Yunita ,
  • Rachmawaddah Yolanda ,
  • Ismir Fahri ,
  • Novriantika Lestari ,
  • Marisadonna Asteria ,
  • Ahmad Azmi Nasution ,
  • Jusup Endang ,
  • Sipriyadi ,
  • Ellen Maidia Djatmiko ,

Abstract

Introduction: Carotid intima-media thickness (CIMT) is a predictor marker of subclinical atherosclerosis that can be measured by ultrasound technique. The clinical symptoms of atherosclerosis usually begin with the thickening of the carotid artery walls. Polymorphism in Apolipoprotein E4 (APO-E4) is considered to be an important genetic determinant of atherosclerosis and Coronary Artery Disease (CAD). The genetic role of APO-E4 on plasma lipid has shown that the APO-E4 allele is associated with increased plasma LDL and total lipid concentration. The main objectives of this study were to identify genotype polymorphisms of the APO-E gene and measure the thickness of the carotid intima in subjects with APO-E4 polymorphisms in the first descendant of coronary heart patients.

Patients and methods: A cross-sectional study design was used to determine the polymorphism of the APO-E4 genotype in the first descendant of CAD and non-CAD groups. There were 21 samples in each group. Gene polymorphism examination was carried out by PCR and the CIMT was measured with doppler ultrasound.

Results: The result showed that 21.4% of subjects had polymorphism of the APO-E4 genotype with a significant difference between CHD and non-CHD group. This data shows that the APO-E4 genotype is more dominant in the first descendant of patients with CHD when compared to non-CHD parents. The mean values of CIMT ini right and left-sided carotid arteries among APO-E4 genotype and non-APO-E4 genotype were 0.4743 mm vs. 0.4195 mm and bivariate analysis showed a significant difference with a P-value of 0.017. This shows that there is a significant difference in the thickness of the carotid intima in the first descendant of subjects who have the APO-E4 genotype and those who do not.

Conclusion: The APO-E4 gene polymorphism was more dominant in the first descendant of CAD patients with a higher CIMT mean value.    

References

  1. Benjamin EJ. et al. Heart disease and stroke statistics - 2018 update: A report from the American Heart Association. Circulation. 2018;137:1-8.
  2. Indonesian Ministry of Health. Basic Health Research.Minsitry of Health. 2018;1689–1699.
  3. Ma WQ, Wang Y, Han XQ, Zhu Y, Liu NF. Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis. BMC Med Genet. 2018;19(1):108. doi: 10.1186/s12881-018-0628-3.
  4. Sandi MR, Martini S, Artanti KD, Widati S. The Description of Modifiable Risk Factors in Coronary Heart Disease At Dr. Soetomo Regional Public Hospital. J Berk Epidemiol. 2019;7:85-92.
  5. Wang Y, Huang Q, Liu J, Wang Y, Zheng G, Lin L, Yu H, Tang W, Huang Z. Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis. Oncotarget. 2017;8(18):30539-30551. doi: 10.18632/oncotarget.15546.
  6. Semaev S, Shakhtshneider E. Genetic Risk Score for Coronary Heart Disease: Review. J Pers Med. 2020;10(4):239. doi: 10.3390/jpm10040239.
  7. Marrzoq LF, Sharif FA, Abed AA. Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip. J Cardiovasc Dis Res. 2011;2(1):29-35. doi: 10.4103/0975-3583.78584.
  8. Saleh RNM, West AL, Ostermann AI, Schebb NH, Calder PC, Minihane AM. APOE Genotype Modifies the Plasma Oxylipin Response to Omega-3 Polyunsaturated Fatty Acid Supplementation in Healthy Individuals. Front Nutr. 2021;8:723813. doi: 10.3389/fnut.2021.723813.
  9. Zhong Z, Wu H, Wu H, Zhao P. Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China. Genet Mol Biol. 2018;41(4):742-749. doi: 10.1590/1678-4685-GMB-2017-0301.
  10. Abyadeh M, Djafarian K, Heydarinejad F, Alizadeh S, Shab-Bidar S. Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis. J Mol Neurosci. 2019;69(4):557-562. doi: 10.1007/s12031-019-01381-1.
  11. Tetik Vardarlı A, Harman E, Bozok Çetintaş V, Kayıkçıoğlu M, Vardarlı E, Zengi A, Küçükaslan AŞ, Eroğlu Z. Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia. Anatol J Cardiol. 2017;17(4):313-321. doi: 10.14744/AnatolJCardiol.2016.7142.
  12. Chen DW, Shi JK, Li Y, Yang Y, Ren SP. Association between ApoE Polymorphism and Type 2 Diabetes: A Meta-Analysis of 59 Studies. Biomed Environ Sci. 2019;32(11):823-838. doi: 10.3967/bes2019.104.
  13. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96(5):1432-7. doi: 10.1161/01.cir.96.5.1432. PMID: 9315528.
  14. Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O'Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Witteman JC, Moons KG, Bots ML. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012;308(8):796-803. doi: 10.1001/jama.2012.9630.
  15. Anwari FA, Novriantika L, Marisadonna A, Sipriyadi EY. VEGF-A Gene Polymorphism (rs2010963) in First Generation of Patients with Coronary Heart Disease. Biology and Science. 2021;4:325–335.
  16. Pursnani S, Merchant M. South Asian ethnicity as a risk factor for coronary heart disease. Atherosclerosis. 2020;315:126-130. doi: 10.1016/j.atherosclerosis.2020.10.007.
  17. Gheisari F, Emami M, Raeisi Shahraki H, Samipour S, Nematollahi P. The Role of Gender in the Importance of Risk Factors for Coronary Artery Disease. Cardiol Res Pract. 2020;2020:6527820. doi: 10.1155/2020/6527820.
  18. Arslan Ince FD, Atay A, Köseoğlu M, Yeşil M, Deveci E. Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism. Anadolu Kardiyol Derg. 2010;10(3):202-8. doi: 10.5152/akd.2010.058.
  19. Cai C, Wen Z, Li L. The relationship between ApoE gene polymorphism and the efficacy of statins controlling hyperlipidemia. Am J Transl Res. 2021;13(6):6772-6777.
  20. Lv P, Zheng Y, Huang J, Ke J, Zhang H. Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins. Neuropsychiatr Dis Treat. 2020;16:2459-2466. doi: 10.2147/NDT.S265194.
  21. Chacko M, Sarma PS, Harikrishnan S, Zachariah G, Jeemon P. Family history of cardiovascular disease and risk of premature coronary heart disease: A matched case-control study. Wellcome Open Res. 2020;5:70. doi: 10.12688/wellcomeopenres.15829.2.
  22. Yousuf FA, Iqbal MP. Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations. Pak J Pharm Sci. 2015;28(4):1439-44.
  23. Ma W, Ren X, Zhang L, Dong H, Lu X, Feng W. Apolipoprotein E Gene Polymorphism and Coronary Artery Disease Risk Among Patients in Northwest China. Pharmgenomics Pers Med. 2021;14:1591-1599. doi: 10.2147/PGPM.S338285.
  24. Kweon SS, Shin MH, Jeong SK, Nam HS, Lee YH, Park KS, Ryu SY, Choi SW, Kim BH, Rhee JA, Zheng W, Choi JS. Cohort Profile: The Namwon Study and the Dong-gu Study. Int J Epidemiol. 2014;43(2):558-67. doi: 10.1093/ije/dys244..
  25. Doliner B, Dong C, Blanton SH, Gardener H, Elkind MSV, Sacco RL, Demmer RT, Desvarieux M, Rundek T. Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study. J Stroke Cerebrovasc Dis. 2018;27(3):645-652. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.053.

How to Cite

Prayogo, A. R. S., Yunita, E. ., Yolanda, R. ., Fahri, I. ., Lestari, N. ., Asteria, M. ., Nasution, A. A. ., Jusup Endang, Sipriyadi, & Djatmiko, E. M. . (2022). Carotid intima-media thickness in the first descendant of coronary artery disease patients with Apolipoprotein-E4 genotype. Bali Medical Journal, 11(3), 1774–1779. https://doi.org/10.15562/bmj.v11i3.3798

HTML
4

Total
8

Share

Search Panel

Ahmad Rafi Satrio Prayogo
Google Scholar
Pubmed
BMJ Journal


Elvira Yunita
Google Scholar
Pubmed
BMJ Journal


Rachmawaddah Yolanda
Google Scholar
Pubmed
BMJ Journal


Ismir Fahri
Google Scholar
Pubmed
BMJ Journal


Novriantika Lestari
Google Scholar
Pubmed
BMJ Journal


Marisadonna Asteria
Google Scholar
Pubmed
BMJ Journal


Ahmad Azmi Nasution
Google Scholar
Pubmed
BMJ Journal


Jusup Endang
Google Scholar
Pubmed
BMJ Journal


Sipriyadi
Google Scholar
Pubmed
BMJ Journal


Ellen Maidia Djatmiko
Google Scholar
Pubmed
BMJ Journal